Hvad er Y-tunnus-nummeret på Janssen-Cilag Oy?

Janssen-Cilag Oy er registreret hos PRH / YTJ under Y-tunnus 0922140-8.

Hvad er omsætningen for Janssen-Cilag Oy?

Janssen-Cilag Oy rapporterede en omsætning på EUR 138,3M i 2024.

Janssen-Cilag Oy beskæftiger 130 personer pr. seneste årsrapport.

Berkeley Alexander Vincent er Chief Executive Officer i Janssen-Cilag Oy, i rollen siden 2019.

Nina Maria Ekholm-Wenberg er bestyrelsesformand i Janssen-Cilag Oy, i rollen siden 2023.

Janssen-Cilag Oys registrerede adresse er Hatsinanpuisto 8-B.

OYActive

Y-tunnus 0922140-8Hatsinanpuisto 8B, 02600 EspooWholesale of pharmaceutical and medical goods · NACE 4646Est. 1993130 employees

Aktivt ansatte i selskabet

Name	Role	Member since
Current (1)
MK Mario Klesse Chief Executive Officer	Chief Executive Officer	2025
Former (6)
BA Berkeley Alexander Vincent Chief Executive Officer	Chief Executive Officer	2019 – 2022
LÅ Lars Åke Hjalmar Johansson Chief Executive Officer	Chief Executive Officer	2011 – 2019
EA Eetu Albert Aleksi Anttonen Audit	Audit	2019 – 2023
BA Berkeley Alexander Vincent Chief Executive Officer	Chief Executive Officer	2019 – 2019
LL Leena Lisette Puumala Audit	Audit	2014 – 2019
DJ Duarte Joäo Lourinho Marchand Chief Executive Officer	Chief Executive Officer	2023 – 2025

Ikke-udøvende tilsyn

Name	Role	Member since
Current (4)
KL Katriina Liina Maria Ingman	Board of Directors	2022
NM Nina Maria Ekholm-Wenberg	Chairperson	2023
RP Raphaël Patricot	Board of Directors	2024
AN Ari-Pekka Naumanen	Board of Directors	2023
Former (7)
PJ Pekka Juhani Ihalmo	Board of Directors	2018 – 2021
TT Terhi Tuuli Elina Lampen	Board of Directors	2018 – 2022
LC Lotta Carola Karlsson	Board of Directors	2022 – 2022
TJ Timothy James House	Board of Directors	2022 – 2024
JA Jukka Arlak Karppinen	Board of Directors	2018 – 2022
SM Susanna Maria Rantala	Board of Directors	2019 – 2022
LJ Liisa Johanna Backman-Laukkanen	Board of Directors	2018 – 2019

Pr. seneste årsrapport

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.